Treatment of heart failure with vasodilator drugs
Pierach, C.A.; Jarosch, P.F.
Münchener Medizinische Wochenschrift 116(39): 1689-1690
1974
ISSN/ISBN: 0341-3098 PMID: 4216778 Document Number: 80316
Document emailed within 1 workday
Related Documents
Cleland, J.G. 1994: Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? British Journal of Hospital Medicine 52(5): 193; 195-196Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Lloyd, E.A. 1979: The use of vasodilator agents in the treatment of heart failure South African Medical Journal 56(20): 787-795
You, K. 1983: The role of vasodilator agents in the emergency treatment of heart failure Zhonghua Nei Ke Za Zhi 22(2): 111-114
Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Mason, D.T.; Awan, N.A.; Demaria, A.N.; Lee, G.; Joye, J.A.; Amsterdam, E.A. 1979: Vasodilator therapy for chronic heart failure Comprehensive Therapy 5(7): 6-14
Bower, P.J. 1982: Vasodilator therapy in congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(2): 36-39
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Ito, T.; Matsumoto, S.; Ito, Y. 1978: Chronic heart failure and vasodilator therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3565-3572
Corbalán, R.; Kunstmann, S.; Jalil, J. 1993: Vasodilator agents in chronic heart failure: which is the best option? Revista Medica de Chile 121(1): 81-88
Groden, D.L. 1993: Vasodilator therapy for congestive heart failure. Lessons from mortality trials Archives of Internal Medicine 153(4): 445-454
Feenstra, J.; Heerdink, E.R.; Grobbee, D.E.; Stricker, B.H.Ch. 2002: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study Archives of Internal Medicine 162(3): 265-270
Mauri, F.; Gronda, E.; Bossi, M.; Rovelli, F. 1980: Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside I.v. and oral prazosin Giornale Italiano di Cardiologia 10(4): 414-423
Sidorenko, B.A.; Preobrazhenskiĭ, D.V. 2005: Changing views on the place of drugs in the treatment of chronic heart failure Kardiologiia 45(3): 90-91
Kersting, F.; Samosny, G.; Kasper, W.; Schuster, H.P. 1981: Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure Die Medizinische Welt 32(26): 1040-1045
Francoual, M.; Nitenberg, A. 1980: Alteration in left ventricular function induced by dihydralazine in severe chronic congestive heart failure: limits of vasodilator therapy? La Nouvelle Presse Medicale 9(19): 1384
Meuser, W.; Dirlich, E. 1976: Stellate ganglion blocks and vasodilator drugs in the treatment of perceptive deafness Laryngologie Rhinologie Otologie 55(1): 66-69
Landström, N.; Kesek, M.; Jensen, S.M. 2013: Too few patients get heart failure pacemakers. it can provide better treatment in heart failure and left bundle branch block Lakartidningen 110(5): 216-219
Gomberg-Maitland, M.; Baran, D.A.; Fuster, V. 2001: Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist Archives of Internal Medicine 161(3): 342-352
Follath, F. 1999: New cardiovascular drugs: expanded therapeutic possibilities in coronary heart disease and in heart failure Praxis 88(18): 809-813